top of page

We Work For Health Statement on Release of CMS’ Prescription Drug Negotiation List

Flawed policy approach impacts growing list of areas of unmet patient need and the American workers who support biopharmaceutical invention


WASHINGTON--(BUSINESS WIRE)--We Work For Health Executive Director Dan Leonard released the following statement in response to the Centers for Medicare and Medicaid Services’ announcement of the first prescription drugs selected for price negotiations under the Inflation Reduction Act (IRA)...



We Work For Health brings together national and local business leaders, labor, biopharma, patient advocacy, and other healthcare-related stakeholders to support policies and initiatives that foster innovation and facilitate the delivery of lifesaving and life-enhancing medicines. 

We Work For Health. © 2023 All Rights Reserved.

bottom of page